Key facts
- It has raised $2.8M; the latest was Later Stage VC ($2.8M) in Jun 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Michun Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Michun Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Michun Biotechnology
Provider of maternal and infant health products intended for early-stage nutritional and developmental support. The company offers precision-formulated supplements, bioactive ingredient integration, and safety-certified production processes, serving healthcare providers and consumer markets to access scientifically backed, high-quality solutions that support infant growth, maternal recovery, and long-term wellness through targeted, age-appropriate, and clinically guided formulations.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Shanghai, China
- Founded
- 2017
- Website
- zhenaimami.com/
- Ownership
- Privately Held (backing)
Michun Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Michun Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Michun Biotechnology in its N-PORT filings yet. We sweep new filings monthly.